Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Neuropsychological features in childhood and juvenile multiple sclerosis: Five-year follow-up.
A Patient Care Program for Adjusting the Autoinjector Needle Depth According to Subcutaneous Tissue Thickness in Patients With Multiple Sclerosis Receiving Subcutaneous Injections of Glatiramer Acetate.
Mechanisms of pain in multiple sclerosis: A combined clinical and neurophysiological study.
School performance as a marker of cognitive decline prior to diagnosis of multiple sclerosis.
Decreased Dicer expression is linked to increased expression of co-stimulatory molecule CD80 on B cells in multiple sclerosis.
Can we measure long-term treatment effects in multiple sclerosis?
Neuro-Ophthalmic Syndromes and Processing Speed in Multiple Sclerosis.
Low Dose Naltrexone for Treatment of Multiple Sclerosis: A Retrospective Chart Review of Safety and Tolerability.
Prevalence of multiple sclerosis in the Lazio region, Italy: use of an algorithm based on health information systems.
Treatment of chronic inflammatory polyneuropathy may improve associated hearing loss: A case report and a review of the literature.
Neuronal activity regulates remyelination via glutamate signalling to oligodendrocyte progenitors.
Cover Images.
The temporal dynamics of visual processing in multiple sclerosis.
Another promising oral agent for multiple sclerosis.
Application of quantitative proteomics technologies to the biomarker discovery pipeline for multiple sclerosis.
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis.
Telephone-based physical activity counseling for major depression in people with multiple sclerosis.
Blood RNA profiling in a large cohort of multiple sclerosis patients and healthy controls.
Can HPV immunisation cause ADEM? Two case reports and literature review.
On the estimation and correction of bias in local atrophy estimations using example atrophy simulations.
Oligodendroglia metabolically support axons and maintain structural integrity.
KIR4.1 Antibodies as Biomarkers in Multiple Sclerosis.
The complex immunology of multiple sclerosis.
Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis.
Treatment responsiveness in CIDP patients with diabetes is associated with unique electrophysiological characteristics, and not with common criteria for CIDP.

Pages